Understanding the Study
This study looked at a Traditional Chinese Medicine called Shugan Jieyu San. It aimed to see if this medicine could help improve liver function and reduce depression in patients with triple negative breast cancer (TNBC).
What the Study Did
- 60 patients with TNBC and depression participated in the study.
- Patients were split into two groups: one group received standard treatment with a medication called duloxetine, while the other group received both the standard treatment and Shugan Jieyu San.
What the Study Found
- Both groups showed improvements in their depressive symptoms and daily activities.
- The group taking Shugan Jieyu San had even better results than the control group.
- Levels of important brain chemicals, dopamine and serotonin, increased in both groups, but were higher in the treatment group with Shugan Jieyu San.
What This Means for Patients
The results suggest that Shugan Jieyu San can help patients with TNBC who are also dealing with depression. It may improve their mood and ability to carry out daily tasks.
What Clinics Can Do
- Start incorporating Shugan Jieyu San into treatment plans for TNBC patients with depression.
- Educate patients about the benefits of this Traditional Chinese Medicine.
Measuring Success
- Track changes in depressive symptoms using questionnaires.
- Monitor improvements in daily living activities.
- Check levels of dopamine and serotonin through blood tests.
Using AI Tools
Clinics can use AI tools to analyze patient responses to treatment and predict which patients may benefit the most from Shugan Jieyu San.
Step-by-Step Plan for Clinics
- Start with a small group of patients to test the use of Shugan Jieyu San in treatment.
- Gather feedback from patients about their experiences.
- Monitor and analyze their health improvements regularly.
- Expand the use of Shugan Jieyu San as more data becomes available.
For more detailed information about the research, you can find it here: Clinical Effect of Shugan Jieyu San.
